Products - Infants and neonates | Topic | NICE

Showing 5 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Rivogenlecleucel for treating haematological non-malignant diseases in children and young people undergoing haploidentical haematopoietic stem cell transplant [ID1496]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Rivogenlecleucel for treating haematological cancers in children and young people undergoing haploidentical haematopoietic stem cell transplant [ID1601]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Perampanel for adjunctive treatment of partial onset or generalised tonic-clonic seizures in children aged below 12 years with epilepsy ID1587
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Teduglutide for treating short bowel syndrome in babies 4 to 12 months [TS ID 10755]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aflibercept for untreated retinopathy in babies born preterm TS ID 11943
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC